MDGL

Madrigal Pharmaceuticals, Inc.

1 day chart

About MDGL

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a proprietary, liver-directed, selective thyroid hormone receptor-B (THR-B), agonist being developed as a once-daily oral pill for the treatment of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). NASH is a liver disease that affects people with metabolic diseases, such as obesity and diabetes and non-alcoholic fatty liver disease (NAFLD).

Buy US stocks in Australia starting with MDGL. Open an account and start investing today!

Market Capitalisation

$5.21B

Price-earnings ratio

Dividend yield

0.00%

Volume

180.61K

High today

$288.75

Low today

$279.01

Open price

$285.77

52-week high

$322.67

52-week low

$57.21

MDGL FAQs

Can I buy MDGL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy MDGL shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Madrigal Pharmaceuticals, Inc.?

One share of Madrigal Pharmaceuticals, Inc. is valued at $280.06.

What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?

The ticker symbol for Madrigal Pharmaceuticals, Inc. is MDGL.

How do I buy MDGL shares in Australia?

To buy MDGL stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in MDGL

What is the 52-week high for Madrigal Pharmaceuticals, Inc. stock?

The Madrigal Pharmaceuticals, Inc. 52-week high stock price is $322.67.

What is the 52-week low for Madrigal Pharmaceuticals, Inc. stock?

The Madrigal Pharmaceuticals, Inc. 52-week low stock price is $57.21.

What is the market capitalisation of Madrigal Pharmaceuticals, Inc. MDGL?

As of 31/05/2023 Madrigal Pharmaceuticals, Inc. has a market cap of $5.2B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.